Clinical Trial Update: L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial of L19IL2 and L19TNF in locally advanced cutaneous squamous cell carcinoma is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• L19IL2 (L19-IL-2)
• L19TNF

Snippet

Sponsor: Philogen S.p.A. | Conditions: Locally Advanced Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING